It noticed that an Israeli NGO had sent a team to Ethiopia during the COVID pandemic. That was a real story. It was not the main story.
NALA is more interesting when viewed across a longer timeline. Founded in Israel but working mainly in East Africa, the organization has spent years trying to solve a basic problem of global public health: medication campaigns alone often do not produce lasting disease control when water, sanitation, education, and local practice stay the same.
That is a much stronger reason to remember NALA than one pandemic deployment.
The organization was built around dissatisfaction with short-term medicine
NALA's own history page gives the founding argument in unusually direct terms. In 2011, founder Zvi Bentwich said he created NALA after realizing that medication alone was not enough to eradicate neglected tropical diseases and that a broader approach was needed.
That is the core of the entire model.
Neglected tropical diseases, or NTDs, are exactly the sort of illnesses that expose the limits of narrow intervention. They flourish where poverty, unsafe water, poor sanitation, and weak health infrastructure overlap. NALA's public materials say these diseases affect almost a quarter of the world's population and can produce blindness, malnutrition, disability, and long-term developmental harm.
If that diagnosis is right, then a narrow delivery model was never going to be enough.
NALA's work is designed to make communities less dependent on outside rescue
The organization now describes itself less as a medical charity than as a prevention-focused public-health operator.
Its official site says NALA works with governments, communities, and schools and uses simple, cost-effective interventions to break chains of transmission while making communities "the architects of their own health." That phrase can sound polished, but the organization has given it a fairly concrete meaning: training health workers and volunteers, improving sanitation and water access, building school-based health education, and trying to embed practices locally rather than flying in with one-off external fixes.
That is an important distinction.
Many NGOs are good at emergency response. Far fewer are set up to care about what happens years after the original intervention ends. NALA's publications list suggests that it is at least trying to judge itself by that harder standard.
The Ethiopia work is where the article becomes credible
The strongest evidence in favor of NALA's model does not come from marketing copy. It comes from a follow-up study.
A 2022 paper coauthored by NALA staff and partners examined a schistosomiasis intervention in Mekele, Ethiopia. The article reports that in 2009 the mean prevalence of schistosomiasis among schoolchildren there was 44.7 percent. NALA and its partners then ran a four-year program across 38 primary schools that combined mass drug administration with behavioral change and water, sanitation, and hygiene improvements.
What makes the study editorially valuable is the follow-up.
Five years after the intervention ended, and ten years after it began, the researchers found that seven of eleven schools in the follow-up sample had kept prevalence below 2 percent. Overall prevalence in 2018 was stable at 0.8 percent. The paper argues that the long-term results support an integrated approach rather than medication alone.
That is the kind of fact that turns an NGO profile into a publishable article.
COVID mattered, but it was not the organization's defining test
The 2020 Ethiopia deployment still belongs in the story. It showed that NALA could mobilize during an acute public-health emergency, train local health workers, and adapt its methods to a pandemic setting.
But if the article stops there, it shrinks the organization back into an emergency anecdote.
The better frame is that COVID revealed an existing organizational instinct. NALA was already built around the idea that durable health work depends on local leadership, behavior change, and public infrastructure. The pandemic did not create that philosophy. It exposed its usefulness under pressure.
That matters because it separates NALA from the more familiar story of Israelis arriving abroad as emergency problem-solvers and then disappearing again once the crisis headline fades.
Why this is also a tikkun olam story
NALA's own board page uses the phrase explicitly. Bentwich describes the organization as a concrete realization of his vision of tikkun olam through the elimination of neglected tropical diseases by an Israel-based organization.
That can sound rhetorical if left untested. The real test is whether the work is built around measurable public benefit rather than moral branding.
Here, the case is reasonably strong. NALA has maintained a research and publication trail, built partnerships with Ethiopian institutions, and framed its work around long-run prevention rather than one-time charity. Even its public writing emphasizes community leadership and local ownership more than donor-centered heroics.
That does not exempt the organization from scrutiny. NGOs should always be judged by evidence, sustainability, and power dynamics. But it does make NALA a better editorial subject than the average feel-good international aid brief.
Why it matters
That is what makes the story durable.
NALA matters because it represents a version of Israeli global engagement that is less about spectacle and more about prevention, systems, and staying power. If the organization succeeds, it does so not by staging dramatic rescues, but by making old diseases less likely to return.
That is quieter work. It is also more serious.